Singh, A. , Sinha, R. , Saran, M. , Kazmi, D. , Gupta, H. and Seth, G. (2025) Efficacy and Safety of Dual Antiplatelet Therapy in High-Risk, Post-Percutaneous Coronary Intervention Patients beyond One ...

In a secondary analysis of the BEST-CLI trial, McGinigle et al found lower rates of major adverse limb events (MALE) and ...

The global Embolic Protection Devices Market is valued at $601 million in 2023 and is projected to reach $1,250 million by ...

近年来，静脉曲张的治疗方式经历了巨大的转变，早已不再单纯以“去除病变静脉”为唯一目标。随着不同领域的研究日益深入，隐静脉保留策略（Saphenous Vein-Sparing Strategy）开始引起越来越多的关注。相关研究表明，在治疗下肢静脉曲张的同时，保留隐静脉结构 ...

Introduction: The presence of non-coronary atherosclerosis (NCA) in patients with coronary artery disease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer ...

Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in ...

The primate brain contains distinct areas densely populated by face-selective neurons. One of these, face-patch ML, contains neurons selective for contrast relationships between face parts. Such ...